BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS: We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS: Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS: These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.).
BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS: We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS: Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS: These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.).
Authors: L L Rodriguez; A De Roo; Y Guimard; S G Trappier; A Sanchez; D Bressler; A J Williams; A K Rowe; J Bertolli; A S Khan; T G Ksiazek; C J Peters; S T Nichol Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226
Authors: Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol Journal: J Virol Date: 2004-04 Impact factor: 5.103
Authors: Neetu Abad; Tasneem Malik; Archchun Ariyarajah; Patricia Ongpin; Matthew Hogben; Suzanna L R McDonald; Jaclyn Marrinan; Thomas Massaquoi; Anna Thorson; Elizabeth Ervin; Kyle Bernstein; Christine Ross; William J Liu; Karen Kroeger; Kara N Durski; Nathalie Broutet; Barbara Knust; Gibrilla F Deen Journal: PLoS Negl Trop Dis Date: 2017-09-11
Authors: Moses J Soka; Mary J Choi; April Baller; Stephen White; Emerson Rogers; Lawrence J Purpura; Nuha Mahmoud; Christine Wasunna; Moses Massaquoi; Neetu Abad; Jomah Kollie; Straker Dweh; Philip K Bemah; Athalia Christie; Victor Ladele; Oneykachi C Subah; Satish Pillai; Margaret Mugisha; Jonathan Kpaka; Stephen Kowalewski; Emilio German; Mark Stenger; Stuart Nichol; Ute Ströher; Kristin E Vanderende; Shauna Mettee Zarecki; Hugh Henry W Green; Jeffrey A Bailey; Pierre Rollin; Barbara Marston; Tolbert G Nyenswah; Alex Gasasira; Barbara Knust; Desmond Williams Journal: Lancet Glob Health Date: 2016-08-30 Impact factor: 26.763
Authors: Boubacar Diallo; Daouda Sissoko; Nicholas J Loman; Hadja Aïssatou Bah; Hawa Bah; Mary Claire Worrell; Lya Saidou Conde; Ramata Sacko; Samuel Mesfin; Angelo Loua; Jacques Katomba Kalonda; Ngozi A Erondu; Benjamin A Dahl; Susann Handrick; Ian Goodfellow; Luke W Meredith; Matthew Cotten; Umaru Jah; Raoul Emeric Guetiya Wadoum; Pierre Rollin; N'Faly Magassouba; Denis Malvy; Xavier Anglaret; Miles W Carroll; Raymond Bruce Aylward; Mamoudou Harouna Djingarey; Abdoulaye Diarra; Pierre Formenty; Sakoba Keïta; Stephan Günther; Andrew Rambaut; Sophie Duraffour Journal: Clin Infect Dis Date: 2016-09-01 Impact factor: 9.079
Authors: Ionara Rabelo; Virginia Lee; Mosoka P Fallah; Moses Massaquoi; Iro Evlampidou; Rosa Crestani; Tom Decroo; Rafael Van den Bergh; Nathalie Severy Journal: Front Public Health Date: 2016-07-04
Authors: Gibrilla Fadlu Deen; Suzanna L R McDonald; Jaclyn E Marrinan; Foday R Sesay; Elizabeth Ervin; Anna E Thorson; Wenbo Xu; Ute Ströher; Patricia Ongpin; Neetu Abad; Archchun Ariyarajah; Tasneem Malik; Hongtu Liu; Christine Ross; Kara N Durski; Philippe Gaillard; Oliver Morgan; Pierre Formenty; Barbara Knust; Nathalie Broutet; Foday Sahr Journal: PLoS Negl Trop Dis Date: 2017-09-11
Authors: John C Kash; Kathie-Anne Walters; Jason Kindrachuk; David Baxter; Kelsey Scherler; Krisztina B Janosko; Rick D Adams; Andrew S Herbert; Rebekah M James; Spencer W Stonier; Matthew J Memoli; John M Dye; Richard T Davey; Daniel S Chertow; Jeffery K Taubenberger Journal: Sci Transl Med Date: 2017-04-12 Impact factor: 17.956
Authors: Xiankun Zeng; Candace D Blancett; Keith A Koistinen; Christopher W Schellhase; Jeremy J Bearss; Sheli R Radoshitzky; Shelley P Honnold; Taylor B Chance; Travis K Warren; Jeffrey W Froude; Kathleen A Cashman; John M Dye; Sina Bavari; Gustavo Palacios; Jens H Kuhn; Mei G Sun Journal: Nat Microbiol Date: 2017-07-17 Impact factor: 17.745
Authors: Mohamed F Jalloh; Rebecca Bunnell; Susan Robinson; Mohammad B Jalloh; Alpha Mamoudou Barry; Jamaica Corker; Paul Sengeh; Amanda VanSteelandt; Wenshu Li; Foday Dafae; Alpha Ahmadou Diallo; Lise D Martel; Sara Hersey; Barbara Marston; Oliver Morgan; John T Redd Journal: Philos Trans R Soc Lond B Biol Sci Date: 2017-05-26 Impact factor: 6.237
Authors: Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou Journal: J Infect Dis Date: 2017-06-15 Impact factor: 5.226
Authors: Pauline Vetter; William A Fischer; Manuel Schibler; Michael Jacobs; Daniel G Bausch; Laurent Kaiser Journal: J Infect Dis Date: 2016-07-20 Impact factor: 5.226